Immunotherapy has become a hot topic for cancer researchers. By using a patient’s own immune cells to attack cancer cells, immunotherapy treatments have shown positive results, including total cancer remission.

To more carefully study immunotherapy as a cancer treatment, scientists need efficient, in vitro screening models to examine targeted therapy options.  The current growing trend is to use more in vivo-like 3D models.

Download this application note from Corning to learn more about a novel 3D immune oncology model for high throughput testing of tumoricidal capability.